Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | +6.81% |
|
+9.61% | -35.31% |
Jun. 24 | Anixa Biosciences Says Sixth Patient Treated in Phase 1 Ovarian Cancer Study | MT |
Jun. 24 | Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial | CI |
- Stock Market
- Equities
- ANIX Stock
- News Anixa Biosciences, Inc.
- Analyst Reco.